Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis

Documenti analoghi

• Cost-Effectiveness of Fluocinolone Acetonide Implant Versus Systemic Therapy for Non-infectious Intermediate, Posterior and Panuveitis
  di: Sugar, Elizabeth A., et al.
  Pubblicazione: (2014)
• Randomized Comparison of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Implant for Intermediate, Posterior and Panuveitis: The Multicenter Uveitis Steroid Treatment Trial
  di: Kempen, John H., et al.
  Pubblicazione: (2011)
• Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior or Panuveitis: 54 month results of The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study
  di: Kempen, John H., et al.
  Pubblicazione: (2015)
• Incidence and outcome of uveitic glaucoma in eyes with intermediate, posterior or panuveitis followed up to 10 years after randomization to fluocinolone acetonide implant or systemic therapy.
  di: Kempen, John H., et al.
  Pubblicazione: (2020)
• Factors Predicting Visual Acuity Outcome in Intermediate, Posterior and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial
  di: Kempen, John H., et al.
  Pubblicazione: (2015)